Riskpilot← Back to searchSign inGet full accessFundus AB
ABActiveOrg 5566043898LundEconomic activity was not specified by tax authority · NACE 0000Est. 20010 employees
Revenue 2025
SEK 0
EBITDA margin
—
+40% vs 2024
Equity ratio
99.7%
Financial strength
Net profit 2025
SEK 275K
+6% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -3K | +40% |
| Net profit | SEK 275K | +6% |
| Total assets | SEK 1,4M | +23% |
| Equity | SEK 1,4M | +26% |
| Employees | 0 | — |
Legal name
Fundus AB
Org number
5566043898
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
3 januari 2001
Share capital
SEK 123 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall utveckla och försälja ögonbottenbildskameror ävensom idka därmed förenlig verksamhet.
Address
Lund
Phone
+46462865750
Email
jonas.tilly@tmed.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −4 | −5 | −4 | −5 | −3 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −4 | −5 | −4 | −5 | −3 |
| Net financials | — | — | — | 14 | 28 |
| Profit before tax | 196 | 195 | 296 | 259 | 275 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 196 | 195 | 296 | 259 | 275 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 344 | 543 | 842 | 1 105 | 1 356 |
| Equity | 327 | 522 | 818 | 1 077 | 1 352 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 17 | 21 | 24 | 27 | 4 |
| Total debt | 17 | 21 | 24 | 27 | 4 |
EBITDA margin
-300000.0%
This company
15.8%
Market median
-1898834% vs market
20212025
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
20.3%
This company
18.4%
Market median
+10% vs market
20212025
Net profit margin
27500000.0%
This company
8.1%
Market median
+339506073% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tilly Medical Products Aktiebolag
Fundus AB Board members of Fundus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Kenneth Jonas Tilly | Chief Executive Officer | 0 companies |
| Lars Konrad Benatti | Deputy Board Member | 0 companies |